Recent developments in the therapy of localized and systemic sclerosis
- 1 April 1994
- journal article
- editorial
- Published by Elsevier in Clinics in Dermatology
- Vol. 12 (2) , 323-332
- https://doi.org/10.1016/s0738-081x(94)90338-7
Abstract
No abstract availableThis publication has 62 references indexed in Scilit:
- Clinical correlations and prognosis based on serum autoantibodies in patients with systemic sclerosisArthritis & Rheumatism, 1988
- D‐penicillamine treatment of lung involvement in patients with systemic sclerosis (scleroderma)Arthritis & Rheumatism, 1987
- D‐penicillamine therapy and interstitial lung disease in scleroderma. a long‐term followup studyArthritis & Rheumatism, 1987
- Effects of diltiazem versus nifedipine on lower esophageal sphincter pressure in patients with progressive systemic sclerosisArthritis & Rheumatism, 1986
- Progressive systemic sclerosis and S-adenosylmethionineClinical Rheumatology, 1985
- The effect of D‐penicillamine on pulmonary findings in systemic sclerosisArthritis & Rheumatism, 1985
- Nifedipine and esophageal dysfunction in progressive systemic sclerosis. A controlled manometric studyArthritis & Rheumatism, 1985
- Trial of platelet‐inhibiting drug in scleroderma double‐blind study with dipyridamole and aspirinArthritis & Rheumatism, 1984
- Treatment of raynaud's phenomenon with ketanserin, a selective antagonist of the serotonin2 (5‐HT2) receptorArthritis & Rheumatism, 1984
- Controlled Double-Blind Trial of Nifedipine in the Treatment of Raynaud's PhenomenonNew England Journal of Medicine, 1983